Letter to Editor: MicroRNA Polymorphism-Related T Helper Type 17/Regulatory T-Cell Imbalance May Lead to Idiopathic Recurrent Pregnancy Loss

AUTHORS

Mehran Panahi ORCID 1 , * , Setareh Jami 1

1 School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

How to Cite: Panahi M, Jami S. Letter to Editor: MicroRNA Polymorphism-Related T Helper Type 17/Regulatory T-Cell Imbalance May Lead to Idiopathic Recurrent Pregnancy Loss, Gene Cell Tissue. Online ahead of Print ; 6(4):e96671. doi: 10.5812/gct.96671.

ARTICLE INFORMATION

Gene, Cell and Tissue: 6 (4); e96671
Published Online: October 20, 2019
Article Type: Letter
Received: July 27, 2019
Revised: October 4, 2019
Accepted: October 5, 2019
Crossmark

Crossmark

CHEKING

READ FULL TEXT

Keywords

Recurrent Pregnancy Loss MicroRNA Polymorphism Type 17 Helper T Cells Regulatory T-Cells

Copyright © 2019, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Dear Editor,

We have read with great interest the recent article by Fazli and Ghorbian describing their study about the “Association study of non-coding RNA miR-499 and miR196a2 gene polymorphisms with the risk of idiopathic recurrent pregnancy loss” (1). We would like to thank the authors for sharing their valuable experience with non-coding RNA gene polymorphisms with the risk of idiopathic recurrent pregnancy loss (RPL). The authors found that the polymorphism of the miR-499 gene had a statistically significant association with the risk of RPL, unlike miR-196a2. They concluded that the miR-499 gene encoding region may be contributed as a genetic predisposition factor to RPL. However, the role of miR-499 and miR196a2 gene polymorphisms in patients with RPL remains unclear.

One of the hypotheses related to RPL is endothelial dysfunction. Moreover, this mechanism could cause placentation-related defects, complicated pregnancy, and probably cause cardiovascular disease in the future (2). Furthermore, we know that inflammatory responses play a critical role in the reproductive system and in RPL (3).

In 2007, Ji et al., reported the results of their study in which they described the miRNA expression signature in the vessel wall (4). Moreover, SNPs in miRNAs (miR-SNPs) can impact reactions and manage miRNA targets related to thrombosis and inflammation pathways in the circulation system (5). Some studies have showed that miRNA polymorphisms (rs11614913 T>C in miR-196a2 and rs3746444 A>G in miR-499) were associated with several endothelial-related diseases (6).

On the other hand, as mentioned above, the inflammatory process and deregulated cytokine production is often observed at the maternal-fetal interface in many cases of RPL (3). Additionally, the equilibrium between Th17 and T regulator (Tregs) is believed to be a prominent factor in the regulation of the immune system (7). Lee et al., reported that the imbalance between Th17 and Treg cells was associated with unexplained RPL pathogenesis (8). Figueiredo and Schumacher, in a review article, demonstrated that a potentially adverse role of Th17 cells in carrying on pregnancies. In addition, they reasoned that the normal human pregnancy is related to rising of the immunosuppressive Treg subset, and Tregs were perceived to play a crucial role in the maintenance of normal immune tolerance (9).

According to the mentioned contents, we hypothesized that miR-SNPs directly (inflammation) and indirectly (endothelial dysfunction) may lead to some molecular mechanisms of pregnancy complications like RPL through changing Th17 and Treg balance. Particularly, nowadays, miRNAs play significant roles in Th17 and Treg cells development, function, and balance in some immune-related diseases (10). Therefore, we suggest that Immune cell assessment, related microRNA profile, and genes polymorphism may serve as a prognostic biomarker for the treatment of patients with RPL and clarifying the role of microRNA polymorphism mechanisms in this complication.

Footnotes

References

  • 1.

    Fazli M, Ghorbian S. Association study of non-coding RNA miR-499 and miR196a2 gene polymorphisms with the risk of idiopathic recurrent pregnancy loss. Gene Cell and Tissue. 2018;5(1). doi: 10.5812/gct.67253.

  • 2.

    Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, et al. Endothelial dysfunction: A link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension. 2007;49(1):90-5. doi: 10.1161/01.HYP.0000251522.18094.d4. [PubMed: 17116761].

  • 3.

    Gupta S, Ahmad G, Tran M, Al Hayaza G, Kayali Z. Pathological roles of oxidative stress (OS) in diseases related to female reproductive system. In: Agarwal A, editor. Oxidative stress in human reproduction. Springer, Cham; 2017. p. 107-27. doi: 10.1007/978-3-319-48427-3_6.

  • 4.

    Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res. 2007;100(11):1579-88. doi: 10.1161/CIRCRESAHA.106.141986. [PubMed: 17478730].

  • 5.

    Vickers KC, Rye KA, Tabet F. MicroRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond). 2014;126(3):183-94. doi: 10.1042/CS20130203. [PubMed: 24102098]. [PubMed Central: PMC3873876].

  • 6.

    Bastami M, Choupani J, Saadatian Z, Zununi Vahed S, Mansoori Y, Daraei A, et al. miRNA polymorphisms and risk of cardio-cerebrovascular diseases: A systematic review and meta-analysis. Int J Mol Sci. 2019;20(2). doi: 10.3390/ijms20020293. [PubMed: 30642078]. [PubMed Central: PMC6359604].

  • 7.

    Knochelmann HM, Dwyer CJ, Bailey SR, Amaya SM, Elston DM, Mazza-McCrann JM, et al. When worlds collide: Th17 and Treg cells in cancer and autoimmunity. Cell Mol Immunol. 2018;15(5):458-69. doi: 10.1038/s41423-018-0004-4. [PubMed: 29563615]. [PubMed Central: PMC6068176].

  • 8.

    Lee SK, Kim JY, Hur SE, Kim CJ, Na BJ, Lee M, et al. An imbalance in interleukin-17-producing T and Foxp3(+) regulatory T cells in women with idiopathic recurrent pregnancy loss. Hum Reprod. 2011;26(11):2964-71. doi: 10.1093/humrep/der301. [PubMed: 21926059].

  • 9.

    Figueiredo AS, Schumacher A. The T helper type 17/regulatory T cell paradigm in pregnancy. Immunology. 2016;148(1):13-21. doi: 10.1111/imm.12595. [PubMed: 26855005]. [PubMed Central: PMC4819144].

  • 10.

    Liu C, Yang H, Shi W, Wang T, Ruan Q. MicroRNA-mediated regulation of T helper type 17/regulatory T-cell balance in autoimmune disease. Immunology. 2018;155(4):427-34. doi: 10.1111/imm.12994. [PubMed: 30133700]. [PubMed Central: PMC6231006].

  • COMMENTS

    LEAVE A COMMENT HERE: